List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1567 studies with search of: "Prostatic Neoplasms"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
Conditions: Prostate Cancer;   Prostatic Cancer;   Prostate Neoplasms;   Prostatic Neoplasms;   Cancer of the Prostate
Intervention: Radiation: CyberKnife Stereotactic Radiosurgery
2 Recruiting CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Conditions: Prostate Cancer;   Prostatic Cancer;   Prostatic Neoplasms;   Prostate Neoplasms;   Cancer of the Prostate
Intervention: Radiation: CyberKnife Stereotactic Radiosurgery
3 Active, not recruiting A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-Resistant Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms;   Cancer of the Prostate
Intervention: Drug: IPI-504
4 Recruiting Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
Conditions: Cancer of the Prostate;   Prostate Cancer;   Prostatic Neoplasms
Interventions: Dietary Supplement: Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E;   Drug: Placebo
5 Recruiting Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
Conditions: Cancer of the Prostate;   Prostate Cancer;   Prostatic Neoplasms
Interventions: Dietary Supplement: Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E;   Drug: Placebo
6 Completed A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy
Conditions: Prostate Cancer;   Cancer of Prostate;   Prostatic Cancer;   Cancer of the Prostate
Intervention: Drug: YM155
7 Recruiting AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer
Conditions: Cancer;   Castrate-Resistant Prostate Cancer;   Mestastatic Prostate Cancer;   Prostate Cancer
Intervention: Drug: AMG 102
8 Recruiting Docetaxel and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms
Interventions: Drug: Docetaxel;   Drug: Imatinib Mesylate
9 Completed Study of Prostate Cancer in Black and White U.S. Veterans
Conditions: Prostate Cancer;   Prostatic Neoplasms
Intervention:
10 Recruiting Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Dietary Supplement: Selenium
11 Not yet recruiting Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator
Conditions: Prostatic Neoplasms;   Cancer of Prostate;   Prostate Cancer;   Prostate Neoplasms
Interventions: Procedure: Laparoscopic Radical Prostatectomy (without a simulator) - no intervention;   Procedure: Laparoscopic Radical Prostatectomy (with a simulator)
12 Completed Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer
Conditions: Stage IV Prostate Cancer;   Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer
Interventions: Drug: docetaxel;   Drug: thalidomide
13 Completed Vector Delivery of the IL-12 Gene in Men With Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Genetic: IL-12 gene
14 Recruiting Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
Conditions: Prostate Cancer;   Prostatic Neoplasms
Interventions: Drug: Panobinostat + bicalutamide;   Drug: Panobinosts+ bicalutamide;   Drug: Panibinostat + bicalutamide
15 Active, not recruiting Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
Conditions: Prostate Cancer;   Hormone Refractory Prostate Cancer;   One Prior Cytotoxic Chemotherapy Regimen
Interventions: Drug: Satraplatin;   Drug: Prednisone
16 Withdrawn Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Stage III Prostate Cancer;   Stage IV Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1;   Drug: bicalutamide;   Drug: flutamide;   Drug: leuprolide acetate;   Procedure: alternative product therapy;   Procedure: antiandrogen therapy;   Procedure: biological therapy;   Procedure: biologically based therapies;   Procedure: cancer prevention intervention;   Procedure: complementary and alternative therapy;   Procedure: differentiation therapy;   Procedure: endocrine therapy;   Procedure: hormone therapy
17 Active, not recruiting The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer
Conditions: Metastatic, Androgen Independent Prostate Cancer;   Prostate Cancer
Interventions: Drug: RAD001;   Drug: Docetaxel
18 Completed Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
Conditions: Hormone Resistant Prostate Cancer;   Metastatic Prostate Cancer
Interventions: Drug: docetaxel;   Drug: estramustine;   Drug: prednisone
19 Active, not recruiting Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy
Conditions: Hormone Refractory Prostate Cancer;   Prostate Cancer
Intervention: Procedure: Phlebotomy
20 Recruiting An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab (AMG 162) in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-Metastatic Prostate Cancer
Conditions: Cancer;   Carcinoma;   Castrate-Resistant Prostate Cancer;   Prostate Cancer;   Tumors
Intervention: Drug: Denosumab

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services